To the Editor: Biallelic mutations in tetratricopeptide repeat domain 7A (TTC7A) gene have been shown to cause several overlapping clinical phenotypes. These include multiple intestinal atresia (MIA) with various degrees of combined immunodeficiency (CID) [1] ; severe form of very early-onset inflammatory bowel disease, apoptotic enterocolitis (AE) [2] ; and immune deficiency-related enteropathy-lymphocytopenia-alopecia (ELA) syndrome [3] . All affected individuals reported to date have presented in first few months of life and all suffered severe life-threatening gastrointestinal (GI) and/or immunological disease manifestations. In the case of MIA, surgical intervention is often necessary early in life. Disease progression and relapses of atresia and stenosis in many patients requires repeat surgeries and small bowel transplantation [4] . Many patients with enteropathy required total parenteral nutrition (TPN). Immunological studies of these patients showed varying degrees of hypogammaglobulinemia and lymphopenia which in some cases was consistent with a diagnosis of severe combined immunodeficiency (SCID).
Here, we report a case presenting with clinical features consistent with common variable immunodeficiency (CVID) and enteropathy but was later found to have compound heterozygous mutations in TTC7A. The patient presented at the age of 15 with lethargy, pallor, and a low body mass index. He was found to be anemic and had low levels of ferritin, folate, Capsule Summary TTC7A deficiency typically causes severe gastrointestinal manifestations such as multiple intestinal atresia or earlyonset inflammatory bowel disease. In some cases, this is associated with severe combined immunodeficiency. Partial loss-of-function mutations appear to be associated with a milder phenotype resulting in common variable immunodeficiency-like condition with enteropathy.
Electronic supplementary material The online version of this article (doi:10.1007/s10875-017-0427-1) contains supplementary material, which is available to authorized users. calcium, and Vitamin D. He did not report any overt diarrhea, abdominal pain, or other symptoms suggestive of small bowel obstruction. He also had no prior history of recurrent or unusual infections. An esophago-gastroduodenoscopy showed an atrophic duodenal mucosa; there was no evidence of any atresia. Histology showed variable villous atrophy and marked lymphocytosis (Fig. 1c) with absence of plasma cells. He was found to have severe panhypogammaglobulinaemia with normal T and B cell numbers but almost absent classswitched memory B cells. Further investigations showed normal proliferative T cell response to PHA and anti-CD3 stimulation and normal neutrophil function tests (Table E1 ). The The dermatological phenotypes of patients C3 and E3 in Bigorgne et al. have also been recently reported [13] features were consistent with diagnosis of CVID; coeliac disease could not be excluded. Gluten-free diet had only a modest effect at alleviating his symptoms. Although he had no history of infections, due to the severity of his panhypogammaglobulinaeamia, he was commenced on immunoglobulin replacement therapy. At the age of 17, the patient was diagnosed with type 1 diabetes mellitus following an admission for diabetic ketoacidosis. He remains free from infections but continues to have difficulties with malabsorption and poor weight gain. The patient gave consent to participate in a study investigating molecular causes of primary immunodeficiencies. Two mutations in TTC7Awere identified by whole exome sequencing (WES): rs139010200, exon 16/20 c.1817 aAg/aGg (K606R); and rs149602485, exon 17/20 c.2014 Tct/Cct (S672P). Sanger sequencing confirmed TTC7A variants in the proband as well as heterozygosity of A1817G paternally and T2014C maternally (Fig. 1b) . No inheritance of affected alleles occurred in healthy siblings ( [5] . We suspect that compound heterozygous combination of K606R and S672P leads to a mild form of disease although we have not identified a clear mechanism by which this occurs. Confirmed pathogenicity of these variants will require in-depth functional analysis and reports of other similar instances.
The biological functions of TTC7A in MIA have been reviewed by L. Notarangelo [6] where this protein is suggested to act as a repressor of RhoA signaling. The administration of ROCK inhibitors is thought to ameliorate proliferative activity and epithelial architecture of the lumen and intestinal crypts. Avitzur et al. identify phosphatidylinositol 4-kinase IIIa (PI4KIIIa) as a major TTC7A-interacting protein [2] . The protein EFR3 homolog B (EFR3B) tethers TTC7A to the plasma membrane thereby allowing localization of PI4KIIIa at the cell membrane. In adult mice, the inactivation of murine PI4KIIIa leads to death due to necrosis of enterocytes in the villi and intestinal crypts [7] . However, the key immunological features of thymic dysplasia and lymphoid depletion in MIA-CID have not yet been explained.
The patient we presented here has a much milder clinical phenotype both in terms of his immunological and GI disease manifestations. We wondered if TTC7A variants found in this patient might have less detrimental effects on the function of the protein. To assess protein expression levels, immunohistochemistry was performed on the patient's small intestine biopsy using rabbit polyclonal TTC7A antibody (Proteintech IL, USA). Hyperplasia is evident in comparison with healthy control (Fig. 1d-f) . No reduction in protein expression was seen. K606R is reported in EXAC with allele frequency 0.002061 including as homozygous. Given the mild phenotype presented here, it is not likely that this SNP alone produces a noticeable effect. A loss of fully functional protein may occur in combination with S672P without any visible reduction in expression. Genome, exome, and clinical panel sequencing in rare diseases generally requires filtering of common SNPs. The contribution toward disease due to mutations with allele frequency greater than 0.001 occurring in a biallelic state may be neglected in cases such as this.
Known variants associated with disease are shown in Table 1 and notated on the gene representation (Fig.  1a) [1-3, 5, 8-13] . This presents an updated list originally compiled by Yang et al. [8] . These variants were mapped on a model of the predicted TTC7A protein structure in Fig. E2 . Modeling was based on the recently reported crystal structure of TTC7B [14] which has high sequence similarity to TTC7A. This reference data was combined with that of other tetratricopeptide repeat (TPR) domains found in a large numbers of proteins [6] (supplemental report E3 and E4). A confidence of 714 residues (81%) was modeled at > 90% accuracy. The TPR domains are identified as cartoons on the ribbon structure (Fig.  E2) .
The variants K606R and S672P have been described in patients as pathogenic but always in association with another more severe alteration. From our model, K606 and S672 lie buried on the beta-turn-beta between TPR domains 6/7 and may not be involved in major interactions resulting in a milder phenotype compared to other variants in the surrounding region.
Limited in vivo models exist for this condition, but it is hopeful that models of human intestine using pluripotent stem cells could allow greater functional study of TTC7A. A precise mechanism shared between gut development and robust immune function is yet to be identified. Our case expands the clinical phenotype associated with biallelic TTC7A mutations. Enteropathy is a relatively common complication of CVID, and as we continue to use more advanced genetic techniques to study this condition, it is possible that these less severe TTC7A variants will be found more frequently in this patient population.
